| Authors: |
Zhang Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ritter J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Brea EJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Dillon DA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Park SR; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA., Liu EM; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA., Tolstorukov MY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA., McGourty WE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lizotte P; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Ivanova EV; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Fahey C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Haratani K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Thai TC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Soroko KM; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Kivlehan S; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Smith EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gokhale PC; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Paweletz CP; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Barbie TU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Breast Surgery, Department of Surgery, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA, USA; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Electronic address: tbarbie@bwh.harvard.edu. |
